These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1680496)

  • 1. CD11c positive B-chronic lymphocytic leukemia.
    Tassies D; Montserrat E; Villamor N; Rozman C
    Blood; 1991 Oct; 78(7):1893. PubMed ID: 1680496
    [No Abstract]   [Full Text] [Related]  

  • 2. CD11c expression in chronic lymphocytic leukemia.
    Palutke M; Tabaczka P; Gingrich D
    Blood; 1992 Nov; 80(10):2685. PubMed ID: 1358261
    [No Abstract]   [Full Text] [Related]  

  • 3. CD5+, CD11C+, trap-positive chronic lymphocytic leukemia/prolymphocytic leukemia.
    Prince HM; Bashford J; van der Weyden MB
    Blood; 1992 Aug; 80(4):1095-6. PubMed ID: 1379851
    [No Abstract]   [Full Text] [Related]  

  • 4. CD11c expression in B-cell chronic lymphocytic leukemia.
    Molica S; Dattilo A; Mannella A
    Blood; 1993 May; 81(9):2466. PubMed ID: 8097635
    [No Abstract]   [Full Text] [Related]  

  • 5. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
    Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
    Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical investigation of normal and chronic lymphocytic leukaemia lymphocytes reveals unexpectedly frequent reactivity with some myelomonocytic associated antibodies.
    Woessner S; Florensa L; Besses C; Vilà RM; Gallés C; Palou L; Sabrafen JS
    Leuk Res; 1992; 16(5):505-10. PubMed ID: 1378160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study.
    Newman RA; Peterson B; Davey FR; Brabyn C; Collins H; Brunetto VL; Duggan DB; Weiss RB; Royston I; Millard FE
    Blood; 1993 Aug; 82(4):1239-46. PubMed ID: 8102560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of LFA-1/CD11a and ICAM-1/CD54 adhesion molecules on neoplastic B cells during in vivo treatment of chronic lymphocytic leukemia with interferon-alpha 2.
    Marotta G; Zagonel V; Pinto A
    Blood; 1993 Jan; 81(1):267-9. PubMed ID: 8093347
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigen density in B-cell chronic lymphocytic leukemia.
    Lavabre-Bertrand T; Poncelet P
    Am J Clin Pathol; 1995 Mar; 103(3):375. PubMed ID: 7872264
    [No Abstract]   [Full Text] [Related]  

  • 10. Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A; Wang CY; McKenzie S; Clarkson BD; Koziner B
    Am J Hematol; 1992 Aug; 40(4):264-9. PubMed ID: 1354412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD5 positive and negative B-CLL. Evidence supporting phenotypic heterogeneity in B-chronic lymphocytic leukemia (B-CLL).
    Faguet GB; Marti GE; Agee JF; Bertin P
    Ann N Y Acad Sci; 1992 May; 651():470-3. PubMed ID: 1376063
    [No Abstract]   [Full Text] [Related]  

  • 12. CD5+ leukemic monocytoid B-cell lymphoma and lymphocytic lymphomas.
    Adami F; Semenzato G; Menestrina F; Chilosi M
    Am J Clin Pathol; 1993 Aug; 100(2):187-8. PubMed ID: 7689294
    [No Abstract]   [Full Text] [Related]  

  • 13. CD1c is not a feature of mixed-cell type but of a typical form of chronic lymphocytic leukaemia.
    Merle-Béral H; Legac E; Chastang C; Michel A; Debré P; Binet JL
    Eur J Haematol; 1992 Feb; 48(2):120. PubMed ID: 1372268
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of chronic lymphocytic leukaemia with myeloid associated antigen.
    Kawamata N; Maruyama Y; Toda S; Takase K; Akiyama H; Sakamaki H; Onozawa Y
    Br J Haematol; 1992 Jan; 80(1):129-30. PubMed ID: 1346967
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of myeloid associated antigens in chronic lymphocytic leukaemia.
    Pinto A; Zagonel V; Carbone A; Del Vecchio L
    Br J Haematol; 1992 Sep; 82(1):173-5. PubMed ID: 1358172
    [No Abstract]   [Full Text] [Related]  

  • 16. CD5 antigen expression in B cell chronic lymphocytic leukaemia.
    Brohée D; Cauchie P; Nève P
    Med Oncol; 1994; 11(3-4):137-8. PubMed ID: 7543349
    [No Abstract]   [Full Text] [Related]  

  • 17. Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukemia: correlation with disease status and neoplastic phenotype.
    Dianzani U; Omedè P; Marmont F; DiFranco D; Fusaro A; Bragardo M; Redoglia V; Giaretta F; Mairone L; Boccadoro M
    Blood; 1994 Apr; 83(8):2198-205. PubMed ID: 7909242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between cell surface activation antigen expression and clinical stage in B-CLL.
    Barnett D; Reilly JT
    Br J Haematol; 1989 Dec; 73(4):572. PubMed ID: 2611146
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of bone marrow growth pattern, coexpression of CD14, and B-cell CD5 antigen density in 45 B-chronic lymphocytic leukemia (B-CLL) patients.
    Paglieroni T; Caggiano V; MacKenzie MR
    Ann N Y Acad Sci; 1992 May; 651():484-5. PubMed ID: 1376066
    [No Abstract]   [Full Text] [Related]  

  • 20. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
    Hulkkonen J; Vilpo L; Hurme M; Vilpo J
    Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.